Results 201 to 210 of about 14,670,208 (357)
Volumetric Microsampling for Patient-Centric Therapeutic Drug Monitoring in Clinical Pharmacology: A Scoping Review. [PDF]
Tummala HP +5 more
europepmc +1 more source
Rationally engineered polymeric interfaces for selective and dynamic recognition of vesicular agents
This review explores how molecularly imprinted polymers can be engineered to recognize complex nanoscale vesicles, including extracellular vesicles and membrane‐enveloped viruses. By tailoring polymer cavities to vesicle surface chemistry and structure, these synthetic receptors support selective detection, separation, and integration with optical ...
Özgecan Erdem +4 more
wiley +1 more source
Therapeutic drug-monitoring-guided desensitization for severe imatinib-associated rash. [PDF]
Dy PS, Lou E.
europepmc +1 more source
Cancer treatment is associated with measurable acceleration of biological aging across epigenetic, telomere, senescence, and immune biomarkers. However, biomarker validation and interventional strategies remain limited, especially in hematologic malignancies, underscoring the need for standardized multi‐omic aging assessments and adequately powered ...
Moataz Ellithi +3 more
wiley +1 more source
Healthcare consumers' perceptions and experiences of an Australian prescription drug monitoring program: a cross-sectional survey. [PDF]
Tay E, Makeham M, Laba TL, Baysari M.
europepmc +1 more source
ABSTRACT Objectives Acute kidney injury (AKI) is a common but often underrecognized complication in ischemic stroke patients undergoing mechanical thrombectomy, particularly among those with pre‐existing renal impairment. This study evaluated the incidence, risk factors, and clinical impact of AKI in this high‐risk population.
Michał Borończyk +10 more
wiley +1 more source
Therapeutic drug monitoring-guided management of venlafaxine overdose in an adolescent: a case report. [PDF]
Krivošová M +6 more
europepmc +1 more source
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Semiannual; Electronic coverage as of Sept. 26, 2006: June 1999/Jan. 2000-; Description based on: June 1999/Jan. 2000 issue; title from cover of PDF (viewed Sept.
Ohio Substance Abuse Monitoring Network.
core
Therapeutic Drug Monitoring and Adverse Drug Reactions: From Signal Detection to Prevention. [PDF]
Algharably E, Gundert-Remy U.
europepmc +1 more source

